TREMFYA is now FDA approved to treat Ulcerative Colitis (UC)

Great news! We’re excited to announce that TREMFYA is now FDA approved to treat Ulcerative Colitis (UC)! Clinical trials were conducted at our Uniontown site, and we are incredibly grateful to all the participants who contributed to making this treatment a reality to help improve the lives of many.

Learn more about this exciting development!

Link for more information:

https://www.jnj.com/media-center/press-releases/tremfya-guselkumab-receives-u-s-fda-approval-for-adults-with-moderately-to-severely-active-ulcerative-colitis-strengthening-johnson-johnsons-leadership-in-inflammatory-bowel-disease#:~:text=September%2011%2C%202024,cells%20that%20produce%20IL%2D23